Earnings-backed filing view

GILEAD SCIENCES, INC. (GILD)

See the latest GILD earnings framing tied back to the filing, including recent revenue and EPS trend context.

Healthcare 10-K Next earnings Date not scheduled

AI filing summary

GILEAD SCIENCES, INC. earnings insights

The filing reads constructive based on revenue and statement momentum.

The latest 10-K for GILD shows revenue was $29.4B and net income was $8.5B.

Key changes

What stands out in the latest report

  • Revenue moved to $29.4B from $28.8B (+2.4% vs prior).
  • Net income moved to $8.5B from $480.0M (+1672.9% vs prior).
  • Diluted EPS moved to $6.78 from $0.38 (+1684.2% vs prior).

Current read

Positive read

Financial snapshot

Latest reported figures

Revenue $29.4B
Net income $8.5B
EPS $6.78
Operating cash flow $10.0B

Trend section

Recent revenue trend

Q3 $7.5B

Period ended 2024-09-30

Q1 $6.7B

Period ended 2025-03-31

Q2 $7.1B

Period ended 2025-06-30

Q3 $7.8B

Period ended 2025-09-30

Trend section

Recent EPS trend

Q3 N/A

Filed period trend snapshot.

Q1 N/A

Filed period trend snapshot.

Q2 N/A

Filed period trend snapshot.

Q3 N/A

Filed period trend snapshot.

Related links

Move through the research workflow

Related companies

Read-throughs worth checking